Small Colony Variants: Introduction, Morphology, Pathogenicity

Introduction

Table of Contents

Small Colony Variants (SCVs) are a subpopulation of bacteria that grow slowly and form unusually small colonies on culture media. They are most commonly described in Staphylococcus aureus, but also occur in Pseudomonas aeruginosa, Escherichia coli, and Listeria monocytogenes. SCVs are associated with chronic, recurrent, and persistent infections due to their altered metabolism and ability to evade host immunity and antibiotics.

Small Colony Variants on CLED agar — Fig. Small Colony Variants of Staphylococcus saprophyticus on CLED agar

Do the above colonies of bacteria, S. saprophyticus, show Small Colony Variants (SCVs)?
Yes. Here is why:

S. No	Features	Observation	SCV Indicator?
1.	Colony size	Some colonies are significantly smaller	Yes
2.	Growth medium	CLED supports E. coli, Staphylococcus, Enterococcus, Klebsiella, etc.	SCVs can form here
3.	Color	Yellow colonies suggest lactose fermentation	Color alone doesn’t rule out SCVs
4.	Heterogeneous population	Both large and very small colonies	Characteristic of mixed SCV and wild-type

Morphology

Colonies are pinpoint-sized, non-pigmented, and often non-hemolytic
Grow more slowly than typical strains
May require supplementation (e.g., hemin, menadione, thymidine) depending on auxotrophy
Under microscope: no distinct morphological difference from wild-type strains

Pathogenicity

SCVs exhibit reduced metabolic activity, allowing intracellular persistence
They evade immune responses by surviving within host cells (e.g., epithelial cells, macrophages)
Known to cause chronic and device-associated infections like:
- Osteomyelitis
- Endocarditis
- Chronic lung infections (especially in cystic fibrosis)
- Prosthetic joint infections
Resistant to many antibiotics, especially those targeting active cell division

Laboratory Diagnosis

Culture:
- Tiny, slow-growing colonies on blood or nutrient agar
- Non-pigmented and often missed without prolonged incubation (48–72 hrs)
Auxotrophy testing:
- SCVs may require hemin, menadione, or thymidine for optimal growth
Biochemical tests:
- Reduced hemolysis, coagulase activity (in staphylococci)
Molecular diagnostics:
- PCR or WGS to confirm identity and resistance genes
Electron microscopy (research): May show altered cell wall thickness

Treatment

SCVs are difficult to eradicate due to intracellular survival and slow growth
Antibiotics with intracellular activity are preferred:
- Rifampicin, clindamycin, linezolid, trimethoprim-sulfamethoxazole
Prolonged antibiotic courses are often needed
Combination therapy may help prevent reversion to wild-type and resistance
Device removal (e.g., catheter, prosthesis) is often required for cure

Prevention

Minimize prolonged antibiotic exposure that may select for SCVs
Maintain strict aseptic techniques during device insertion and surgery
Regular monitoring in patients with chronic infections (e.g., CF, osteomyelitis)
Infection control in healthcare settings, especially in long-term care units

Keynotes

SCVs are a phenotypic variant, not a separate species
Common in chronic, relapsing infections, especially involving biofilms and intracellular niches
Often auxotrophic for essential growth factors like hemin or thymidine
Misidentification or underdetection can delay proper treatment
Require prolonged and targeted therapy for successful eradication
Associated with antibiotic tolerance rather than classical resistance

Small Colony Variants: Introduction, Morphology, Pathogenicity, Lab Diagnosis, Treatment, Prevention, and Keynotes